A detailed history of Janney Montgomery Scott LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 8,942 shares of UTHR stock, worth $3.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,942
Previous 8,960 0.2%
Holding current value
$3.16 Million
Previous $2.06 Million 38.39%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$228.26 - $319.04 $4,108 - $5,742
-18 Reduced 0.2%
8,942 $2.85 Million
Q1 2024

May 01, 2024

BUY
$210.76 - $249.51 $42,362 - $50,151
201 Added 2.29%
8,960 $2.06 Million
Q4 2023

Feb 07, 2024

SELL
$214.88 - $256.94 $10,744 - $12,847
-50 Reduced 0.57%
8,759 $1.93 Million
Q3 2023

Nov 08, 2023

BUY
$211.82 - $248.24 $270,917 - $317,498
1,279 Added 16.99%
8,809 $1.99 Million
Q2 2023

Jul 26, 2023

SELL
$205.19 - $232.99 $105,057 - $119,290
-512 Reduced 6.37%
7,530 $1.66 Million
Q1 2023

Apr 28, 2023

SELL
$212.99 - $276.17 $22,576 - $29,274
-106 Reduced 1.3%
8,042 $1.8 Million
Q4 2022

Feb 01, 2023

SELL
$205.95 - $280.43 $273,501 - $372,411
-1,328 Reduced 14.01%
8,148 $2.27 Million
Q3 2022

Oct 25, 2022

BUY
$203.3 - $244.17 $48,182 - $57,868
237 Added 2.57%
9,476 $1.98 Million
Q2 2022

Aug 03, 2022

BUY
$174.81 - $241.14 $31,116 - $42,922
178 Added 1.96%
9,239 $2.16 Million
Q1 2022

May 04, 2022

SELL
$166.16 - $213.96 $18,111 - $23,321
-109 Reduced 1.19%
9,061 $1.63 Million
Q4 2021

Jan 27, 2022

SELL
$184.32 - $216.08 $21,749 - $25,497
-118 Reduced 1.27%
9,170 $1.98 Million
Q3 2021

Oct 29, 2021

BUY
$179.86 - $214.88 $380,763 - $454,900
2,117 Added 29.52%
9,288 $1.71 Million
Q2 2021

Jul 26, 2021

BUY
$170.47 - $211.93 $1.22 Million - $1.52 Million
7,171 New
7,171 $1.29 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.1B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.